Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed NSCLC stage IB–IIIB (N2); 2. Age >=18 years; 3. Patient has been evaluated by a multidisciplinary team and is scheduled to receive neoadjuvant immunotherapy or chemoimmunotherapy (PD-1/PD-L1 inhibitors) followed by surgery; 4. Body Mass Index (BMI) >=18.5 and self-reported weight loss <10% within the past month; 5. ECOG performance status (PS) <=2; 6. No contraindications to exercise training, such as myocardial infarction or stroke within the past 6 months, chronic heart failure, unstable angina, severe arrhythmias, significant left ventricular dysfunction, acute pulmonary embolism, severe peripheral vascular disease or limb dysfunction; 7. Willingness to participate and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Evidence of distant metastasis or other malignancies on imaging; 2. Inability to cooperate due to mental illness, consciousness disorder, or cognitive impairment; 3. Unable to tolerate exercise training; 4. Presence of any contraindications to physical activity (e.g., myocardial infarction or stroke within 6 months, chronic heart failure, unstable angina, severe arrhythmias, significant left ventricular dysfunction, acute pulmonary embolism, severe peripheral vascular disease or limb dysfunction); 5 Other exercise-related contraindications such as active hemoptysis or untreated pneumothorax; 6. Pregnant or breastfeeding individuals; 7. Unwillingness or inability to comply with study requirements; 8. Daily activity level >=6 METs; 9. BMI =10% self-reported weight loss in the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VO2 peak; | — |
Secondary
| Measure | Time frame |
|---|---|
| Exercise endurance;Physical activity level;Immune function indicators;Treatment toxicity;Treatment completion;Quality of life and emotional stress; | — |
Countries
China
Contacts
West China Hospital, Sichuan University